← FDA Drug Approvals (Drugs@FDA)

ONDANSETRON

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IPCA LABS LTD · Approved 2023-10-30

Drug application

FDA Application #

ANDA209389

Application type

Abbreviated New Drug Application (Generic)

Brand name

ONDANSETRON

Generic name

ONDANSETRON

Active ingredients

ONDANSETRON

Dosage form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Marketing status

Prescription

Sponsor

IPCA LABS LTD

Manufacturer

Ipca Laboratories Limited

First approval

2023-10-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown